Denali Therapeutics
DNLI
DNLI
230 hedge funds and large institutions have $1.93B invested in Denali Therapeutics in 2025 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 83 increasing their positions, 64 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 221 → 230 (+9)
3.21% more ownership
Funds ownership: 91.5% → 94.71% (+3.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
230
Holding in Top 10
1
Calls
$2.08M
Puts
$630K
Top Buyers
| 1 | +$45.4M | |
| 2 | +$31M | |
| 3 | +$31M | |
| 4 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$8.39M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$6.56M |
Top Sellers
| 1 | -$80.4M | |
| 2 | -$24.9M | |
| 3 | -$11.9M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$11M |
| 5 |
Squarepoint
New York
|
-$9.34M |
